Sana Biotechnology

SANA • NASDAQ • Stock Fundamentals

Sana Biotechnology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven D. Harr, with a market cap of $770.9M.

Market Cap$770.9M

Employees328.0

CEOSteven D. Harr

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Sana Biotechnology

Sana Biotechnology (SANA) has a market capitalization of $770.9M and trades on NASDAQ.

Sana Biotechnology has approximately 328 employees.